NCT01986608View on ClinicalTrials.gov

Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Lacosamide infusion

"Strength: 10 mg/mL for infusion~Form: solution for infusion~Dosage: 200 mg, single dose~Duration: 30-minute infusion or 60-minute infusion"

DRUG

Lacosamide oral

"Strength: 200 mg~Form: film-coated tablet~Dosage: 200 mg, single dose~Duration: single oral intake"

Trial Locations (1)

Unknown

001, Harrow

All Listed Sponsors
lead

UCB Pharma SA

INDUSTRY

NCT01986608 - Bioavailability/Bioequivalence Study Between Lacosamide Tablet and Solution for Infusion in Healthy Japanese Subjects | Biotech Hunter | Biotech Hunter